跳至主要内容
临床试验/NCT01538017
NCT01538017已完成不适用

Comparing Injectable Collagenase (CI) and Percutaneous Needle Fasciotomy (PNF) for Dupuytren's Contracture (DC) Affecting Proximal Interphalangeal Joints (PIP). A Randomised Controlled Trial

Jeppe Lange, MD1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2012年2月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
50
试验地点
1
主要终点
Clinical improvement

研究概览

简要总结

Comparing injectable collagenase and percutaneous needle fasciotomy for Dupuytren's contracture affecting proximal interphalangeal joints. An open label, medico-independent randomized controlled trial.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 99 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • DC affecting PIP joint with Passive Extension Deficit (PED) more than 20 degrees
  • Clearly defined strings

排除标准

  • Allergies to used medication
  • International Normalised Ratio more than 2.0
  • Pregnancy and breastfeeding
  • Previous treatment for DC in affected finger
  • Former inclusion in the study with another string
  • Activity in disease at time of study
  • PED more than 20 degrees for Metacarpophalangeal or Distal Interphalangeal joint in affected digit

研究组 & 干预措施

Collagenase injection

Active Comparator

Injection of collagenase obtained from Clostridium Histolyticum in contracture string

干预措施: Xiapex (Drug)

Percutaneous needle fasciotomy

Active Comparator

PNF ad modum Lermusiaux and Debeyre

干预措施: Percutaneous needle fasciotomy (Procedure)

结局指标

主要结局

Clinical improvement

时间窗: 2 years

Clinical improvement is defined as a contracture reduction 50% or more from baseline.

次要结局

未报告次要终点

研究者

发起方
Jeppe Lange, MD
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Jeppe Lange, MD

M:D:

Regionshospitalet Silkeborg

研究点 (1)

Loading locations...

相似试验